The content on this site is intended for healthcare professionals only
Attributable risks for hepatocellular carcinoma in the USA
Dr Katherin McGlynn - National Cancer Institute, USA
6 May 2010
European Association for Cancer Research
Prof Anne-Lise Borresen-Dale - President of the European Association for Cancer ...
5 Nov 2009
European action against rare cancers
Dr Paolo Casali - Executive Commitee Member, European Society for Medical Oncol...
4 Nov 2009
ECCO 15 - ESMO 34 Conference
Prof José Baselga - President of ESMO
4 Nov 2009
New targeted drugs for metastatic renal cell carcinoma
Dr Joaquim Bellmunt - Section Chief, Solid Tumor Oncology, Hospital del Mar, Bar...
25 Sep 2009
ECCO 15 - ESMO 34 News 23rd September 2009
Prof Gordon McVie - ecancer Managing Editor
23 Sep 2009
ECCO 15 - ESMO 34 News 22nd September 2009
Prof Gordon McVie - ecancer Managing Editor
22 Sep 2009
ECCO 15 - ESMO 34 News 20-21 September, 2009
Prof Gordon McVie - ecancer Managing Editor
21 Sep 2009
ECCO 15 - ESMO 34 Chairs: Why join us in Berlin?
Why attend ECCO 15 - ESMO 34?
22 Jul 2009
The Oncopolicy Roundtable: ECCO's President and special guests highlight key iss...
ECCO 15 - ESMO 34
22 Jul 2009
AACR 2009: Common genetic variations and predisposition to cancer
Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
14 May 2009
AACR 2009: 100 years of AACR
Dr Margaret Foti - CEO of the American Association for Cancer Research
14 May 2009